Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies.
AUTOR(ES)
Mercer, W E
RESUMO
Two monoclonal antibodies against the p53 protein, PAb 122 and 200-47, were microinjected into mammalian cells as a probe to determine the role of the p53 protein in cell proliferation. PAb 122 recognizes the p53 proteins of mouse and human cells but not of hamster cells, whereas 200-47 recognizes the p53 proteins of mouse and hamster cells but not of human cells. The ability of these antibodies to inhibit serum-stimulated DNA synthesis of cells in culture correlates with their ability to recognize the species-specific antigenic determinants. More important, however, is the observation that microinjected PAb 122 inhibits the transition of Swiss 3T3 cells from G0 to S phase, but has no effect on the progression of these cells from mitosis to the S phase.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=368692Documentos Relacionados
- Time-dependent maturation of the simian virus 40 large T antigen-p53 complex studied by using monoclonal antibodies.
- Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.
- Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies.
- p53 functions as a cell cycle control protein in osteosarcomas.
- Reinitiation of DNA Synthesis and Cell Division in Senescent Human Fibroblasts by Microinjection of Anti-p53 Antibodies